| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55fa76c9b7175910a5bffb3e26fb5b2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2019-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30df9d8737bc8202559dae412a8b12ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f847ee2851456b24a62617d2dc01634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab9370ef551ba25a6f86695fa345fffd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2140bdabe53250a270ba812a1228694d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42b9bbb39357cd57e5ca38653a46f851 |
| publicationDate |
2021-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3810651-A1 |
| titleOfInvention |
Anti-pd-1 antibodies and uses thereof |
| abstract |
Methods of treatment of cancer with antibodies and antibody fragments that bind to PD-1 are disclosed. |
| priorityDate |
2018-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |